Allan, and then you have the Biomarker data that has only come to light recently showing extreme efficacy when using the Magic poor prognosis scores, where these cells make a massive difference.
The Magic control cohorts were between 10 and 30% probability of survival, versus those matching the Magic >0.29 score, that MSB treated having 64% survival in the GVHDD 001 trial.
They have also expanded the comparison to include the EAP children who also match the Magic algorithm, and I bet this will show the same extreme efficacy levels.
There is nothing that I know of for children SrGvHD and > 0.29 that is anywhere near as effective. Probably why it's approved in Japan an going gangbusters already
Why are PNV holders frequenting MSB?, page-14
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |